105 related articles for article (PubMed ID: 29396235)
1. Investigation of treatment pattern, medical resource utilization and demographic prognostic factors in older patients with non-Hodgkin lymphoma: A nationwide population-based study.
Cho SF; Wu WH; Yang YH; Liu YC; Hsiao HH; Chang CS
J Geriatr Oncol; 2018 Jul; 9(4):315-320. PubMed ID: 29396235
[TBL] [Abstract][Full Text] [Related]
2. Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?
Lee SH; Yoo KH; Sung KW; Ko YH; Lee JW; Koo HH
Pediatr Blood Cancer; 2013 Nov; 60(11):1842-7. PubMed ID: 23857875
[TBL] [Abstract][Full Text] [Related]
3. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
[TBL] [Abstract][Full Text] [Related]
5. Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).
You B; Salles G; Bachy E; Casasnovas O; Tilly H; Ribrag V; Sebban C; Hénin E; Guitton J; Tod M; Freyer G
Cancer Chemother Pharmacol; 2015 Nov; 76(5):939-48. PubMed ID: 26391155
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Ancochea Á; Salar A; García-Pallarols F; Gimeno E; Fernández-Rodriguez C; Sánchez-González B
Med Clin (Barc); 2015 Jun; 144(12):544-7. PubMed ID: 25110180
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of treatment for spinal cord compression due to primary non-Hodgkin lymphoma.
Tang Y; Yang X; Xiao J; Liu K; Yan W; Song D; Qu J; Ma J; Wan W
Spine J; 2013 Jun; 13(6):641-50. PubMed ID: 23337542
[TBL] [Abstract][Full Text] [Related]
10. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
Tallarico M; Foster JC; Seisler D; Lafky JM; Hurria A; Jatoi A; Cohen HJ; Muss HB; Bartlett N; Cheson BD; Jung SH; Leonard JP; Byrd JC; Nabhan C
J Geriatr Oncol; 2018 Jul; 9(4):321-328. PubMed ID: 29673807
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma in the older person: a review.
Ballester OF; Moscinski L; Spiers A; Balducci L
J Am Geriatr Soc; 1993 Nov; 41(11):1245-54. PubMed ID: 7693787
[TBL] [Abstract][Full Text] [Related]
12. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
14. Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma.
Cronin DP; Harlan LC; Clegg LX; Stevens JL; Yuan G; Davis TA
Hematol Oncol; 2005 Jun; 23(2):73-81. PubMed ID: 16170828
[TBL] [Abstract][Full Text] [Related]
15. High dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ) followed by autologous stem cell support in 100 consecutive lymphoma patients in a single centre: analysis of efficacy, toxicity and prognostic factors.
Waheed F; Kancherla R; Seiter K; Liu D; Qureshi Z; Hoang A; Ahmed T
Leuk Lymphoma; 2004 Nov; 45(11):2253-9. PubMed ID: 15512814
[TBL] [Abstract][Full Text] [Related]
16. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
Maksymiuk AW; Haines C; Tan LK; Skinnider LF
Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital.
Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM
Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842
[TBL] [Abstract][Full Text] [Related]
18. Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma.
Kleinstern G; Averbuch M; Abu Seir R; Perlman R; Ben Yehuda D; Paltiel O
Hematol Oncol; 2018 Apr; 36(2):457-462. PubMed ID: 29469175
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
Orlandi E; Lazzarino M; Brusamolino E; Castelli G; Pagnucco G; Morra E; Bernasconi C
Haematologica; 1991; 76(3):204-8. PubMed ID: 1743590
[TBL] [Abstract][Full Text] [Related]
20. Demographic and rural-urban variations in dental service utilization in Taiwan.
Wen PC; Lee CB; Chang YH; Ku LE; Li CY
Rural Remote Health; 2017; 17(3):4161. PubMed ID: 28838246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
